Rosenow F, Haupt W F, Grieb P, Jiménez-Klingberg C, Borberg H
Department of Neurology, University of Koln, Germany.
Transfus Sci. 1993 Jan;14(1):13-5. doi: 10.1016/0955-3886(93)90047-X.
Selective adsorption is a new method of treating Guillain-Barré syndrome. Its therapeutic effects and its concomitant side effects were compared between plasma exchange and symptomatic treatment only. The clinical study of three groups of 10 Guillain-Barré patients, each matched for age and maximal disability, was analyzed. Selective adsorption compared favorably with plasma exchange in shortening the time to first improvement and duration of in-hospital treatment. Side effects were similar in both groups. Symptomatic arteriosclerosis should be considered a relative contraindication for selective adsorption.
